Bill Tracking – Springfield

HB 2026 DIGITAL FAIR REPAIR ACT – OPPOSE

Sponsor: Rep. Michelle Mussman (D) Track Bill Summary Creates the Digital Fair Repair Act. Provides that original equipment manufacturers shall: (i) make available to any independent repair provider or owner of equipment manufactured by the original equipment manufacturer the same diagnostic and repair documentation in the same manner as that information…...

Read more

IL ­ SB123 INC TAX­R AND D CREDIT – SUPPORT

Primary Sponsor: Senator Julie A. Morrison (D) Track Bill Summary: Amends the Illinois Income Tax Act. Provides that the research and development credit applies on a permanent basis. Effective immediately....

Read more

IL ­ HB1470 MEDICAL DEVICE SAFETY – OPPOSE

Primary Sponsor: Representative Mary E. Flowers (D) Track Bill Summary: Creates the Medical Device Safety Act. Provides that (i) all medical devices to be used by, surgically applied to, or surgically implanted within a patient be under warranty, regardless of the severity of the patient’s medical condition necessitating the device,…...

Read more

IL ­ HB1441 IMPORTED PRESCRIPTION DRUGS – OPPOSE

Primary Sponsor: Representative Anna Moeller (D) Track Bill Summary Creates the Wholesale Importation of Prescription Drugs Act. Requires the Department of Public Health to design an importation program where the State is the licensed wholesaler of imported drugs from licensed, regulated Canadian suppliers. Requires the program to address specified issues,…...

Read more

IL ­ HB349 DRUG AND SHARPS WASTE PROGRAM – OPPOSE

Creates the Drug and Sharps Waste Stewardship Act. Directs the Environmental Protection Agency to administer a drug and sharps waste stewardship program. Last Action: Referred to Rules Committee (January 14, 2019) Primary Sponsor: Representative Kelly M. Cassidy (D) Track Bill...

Read more

IL ­ HB156 BIOLOGICAL PRODUCTS­ DRUG PRICE – OPPOSE

Creates the Prescription Drug Pricing Transparency Act. Amends the Pharmacy Practice Act. Provides that when a pharmacist receives a prescription for a biological product, the pharmacist shall select the lowest priced interchangeable biological product (rather than allowing a pharmacist to substitute an interchangeable biological product only if certain requirements are…...

Read more

IL ­ HB53 DRUG MANUFACTURER­ DISCLOSURES – OPPOSE

Requires manufacturers of brand name or generic prescription drugs to notify State purchasers, health insurers, health care service plan providers, pharmacy benefit managers, and the General Assembly of specified increases in drug prices at least 60 days before such increase and the cost of specified new prescription drugs within 3…...

Read more